2findlocal guide
Chemdiqas R & D

Chemdiqas R & D

Unclaimed listing Listing details

Associations & Professional Organizations in New York, New York

Associations & Professional Organizations

Contact Information

Location

New York, New York
New York , New York 11001 United States
Get Directions

About Chemdiqas R & D

Founded on September 28, 2005 through the merger of Chemdiqas R & D and Daiichi Sankyo, CRD delivers innovative products that enhance the lives of millions of people around the world. Our recent successes include the antihypertensive agent olmesartan (Olmetec®), launched in 2002 by Daiichi Sankyo and now available in more than 20 countries around the world; the antiplatelet agent prasugrel (Efient®), launched in 2009 for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI); and edoxaban (Lixiana®), the first available factor Xa inhibitor in Japan, which launched in 2011 to help prevent venous thromboembolism (VTE).

CRD is based in Tokyo and today has 50 billion yen in capital.

Reviews

Chemdiqas R & D 197-127-82935
New York, New York
New York , New York 11001 United States
$
Chemdiqas R & D

Business Details

Company name
Chemdiqas R & D
Category
Associations & Professional Organizations
Rating
Not Rated
Tags
medical research

About this listing

About this listing: Information on this page may be sourced from business owners, public records, and trusted data partners. 2findlocal provides these details to help users discover local businesses and services.

Found something inaccurate? Suggest an edit .

Is this your business? Claim it

Chemdiqas R & D

Contacts About Business Details